BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: . Chapter 3: Use of ESAs and other agents to treat anemia in CKD. Kidney Int Suppl (2011) 2012;2:299-310. [PMID: 25018950 DOI: 10.1038/kisup.2012.35] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Wittbrodt ET, James G, Kumar S, van Haalen H, Chen H, Sloand JA, Kalantar-Zadeh K. Contemporary outcomes of anemia in US patients with chronic kidney disease. Clin Kidney J 2022;15:244-52. [PMID: 35145639 DOI: 10.1093/ckj/sfab195] [Reference Citation Analysis]
2 Liu CT, Lin YC, Lin YC, Kao CC, Chen HH, Hsu CC, Wu MS. Roles of Serum Calcium, Phosphorus, PTH and ALP on Mortality in Peritoneal Dialysis Patients: A Nationwide, Population-based Longitudinal Study Using TWRDS 2005-2012. Sci Rep 2017;7:33. [PMID: 28232731 DOI: 10.1038/s41598-017-00080-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
3 Lopes MB, Tu C, Zee J, Guedes M, Pisoni RL, Robinson BM, Foote B, Hedman K, James G, Lopes AA, Massy Z, Reichel H, Sloand J, Waechter S, Wong MMY, Pecoits-Filho R. A real-world longitudinal study of anemia management in non-dialysis-dependent chronic kidney disease patients: a multinational analysis of CKDopps. Sci Rep 2021;11:1784. [PMID: 33469061 DOI: 10.1038/s41598-020-79254-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
4 Tonelli M, Thadhani R. Anaemia in chronic kidney disease: what do new generation agents offer? The Lancet 2022. [DOI: 10.1016/s0140-6736(22)00120-9] [Reference Citation Analysis]
5 Locatelli F, Del Vecchio L, Luise MC. Current and future chemical therapies for treating anaemia in chronic kidney disease. Expert Opin Pharmacother 2017;18:781-8. [PMID: 28443351 DOI: 10.1080/14656566.2017.1323872] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
6 Clark B, Woolford SM, Eastwood A, Sharpe K, Barnes PG, Gore CJ. Temporal changes in physiology and haematology in response to high- and micro-doses of recombinant human erythropoietin: Temporal responses to high- and micro-doses of rHuEPO. Drug Test Analysis 2017;9:1561-71. [DOI: 10.1002/dta.2176] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 4.2] [Reference Citation Analysis]
7 Hodson EM, Strippoli GFM. Long- or short-acting erythropoiesis-stimulating agents: take no shortcuts in their evaluation. Nephrol Dial Transplant 2021;36:205-7. [PMID: 32582928 DOI: 10.1093/ndt/gfaa118] [Reference Citation Analysis]
8 Nagai K, Yamagata K. Use of darbepoetin alfa for myelodysplastic syndrome coincident with chronic kidney disease. CEN Case Rep 2016;5:117-8. [PMID: 28509181 DOI: 10.1007/s13730-016-0212-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
9 Chao CT, Lai CF, Huang JW, Chiang CK, Huang SJ. Association of increased travel distance to dialysis units with the risk of anemia in rural chronic hemodialysis elderly. Hemodial Int 2015;19:44-53. [PMID: 24923997 DOI: 10.1111/hdi.12187] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
10 Hara A, Koshino Y, Kurokawa Y, Shinozaki Y, Miyake T, Kitajima S, Toyama T, Iwata Y, Sakai N, Shimizu M, Furuichi K, Nakamura H, Wada T. Relationship between anti-erythropoietin receptor autoantibodies and responsiveness to erythropoiesis-stimulating agents in patients on hemodialysis: a multi-center cross-sectional study. Clin Exp Nephrol 2020;24:88-95. [PMID: 31502102 DOI: 10.1007/s10157-019-01787-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Yang H, Juang SY, Liao KF, Chen YH. Comparing the Effect of Folic Acid and Pentoxifylline on Delaying Dialysis Initiation in Patients with Advanced Chronic Kidney Disease. Nutrients 2019;11:E2192. [PMID: 31547288 DOI: 10.3390/nu11092192] [Reference Citation Analysis]
12 Sibbel SP, Koro CE, Brunelli SM, Cobitz AR. Characterization of chronic and acute ESA hyporesponse: a retrospective cohort study of hemodialysis patients. BMC Nephrol 2015;16:144. [PMID: 26283069 DOI: 10.1186/s12882-015-0138-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 2.9] [Reference Citation Analysis]
13 Cunha GJ, Rocha BM, Menezes Falcão L. Iron deficiency in chronic and acute heart failure: A contemporary review on intertwined conditions. European Journal of Internal Medicine 2018;52:1-7. [DOI: 10.1016/j.ejim.2018.04.013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
14 Begum S, Latunde-Dada GO. Anemia of Inflammation with An Emphasis on Chronic Kidney Disease. Nutrients 2019;11:E2424. [PMID: 31614529 DOI: 10.3390/nu11102424] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
15 Chuengsaman P, Narenpitak S, Sritippayawan S. Efficacy and safety of recombinant human erythropoietin (Hema-Plus®) for management of anemia in Thai patients on peritoneal dialysis. World J Nephrol 2021; 10(6): 109-121 [PMID: 34909408 DOI: 10.5527/wjn.v10.i6.109] [Reference Citation Analysis]
16 D'Costa MR, Winkler NS, Milliner DS, Norby SM, Hickson LJ, Lieske JC. Oxalosis Associated With High-Dose Vitamin C Ingestion in a Peritoneal Dialysis Patient. Am J Kidney Dis 2019;74:417-20. [PMID: 30910370 DOI: 10.1053/j.ajkd.2019.01.022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
17 Goldsmith D, Dellanna F, Schiestl M, Krendyukov A, Combe C. Epoetin Biosimilars in the Treatment of Renal Anemia: What Have We Learned from a Decade of European Experience? Clin Drug Investig 2018;38:481-90. [PMID: 29500617 DOI: 10.1007/s40261-018-0637-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
18 Lobo B, Abdel-Rahman E, Brown D, Dunn L, Bowman B. A recurrent neural network approach to predicting hemoglobin trajectories in patients with End-Stage Renal Disease. Artif Intell Med 2020;104:101823. [PMID: 32499002 DOI: 10.1016/j.artmed.2020.101823] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
19 Gluba-Brzózka A, Franczyk B, Olszewski R, Rysz J. The Influence of Inflammation on Anemia in CKD Patients. Int J Mol Sci 2020;21:E725. [PMID: 31979104 DOI: 10.3390/ijms21030725] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
20 Yamamoto H, Nishi S, Tomo T, Masakane I, Saito K, Nangaku M, Hattori M, Suzuki T, Morita S, Ashida A, Ito Y, Kuragano T, Komatsu Y, Sakai K, Tsubakihara Y, Tsuruya K, Hayashi T, Hirakata H, Honda H. 2015 Japanese Society for Dialysis Therapy: Guidelines for Renal Anemia in Chronic Kidney Disease. Ren Replace Ther 2017;3. [DOI: 10.1186/s41100-017-0114-y] [Cited by in Crossref: 81] [Cited by in F6Publishing: 20] [Article Influence: 16.2] [Reference Citation Analysis]
21 Papadopoulos G, Dounousi E, Papathanasiou A, Papathanakos G, Tzimas P. Cerebral oximetry values in dialyzed surgical patients: a comparison between hemodialysis and peritoneal dialysis. Ren Fail 2013;35:855-9. [PMID: 23713678 DOI: 10.3109/0886022X.2013.794675] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
22 Wilhelm-Leen ER, Winkelmayer WC. Mortality risk of darbepoetin alfa versus epoetin alfa in patients with CKD: systematic review and meta-analysis. Am J Kidney Dis 2015;66:69-74. [PMID: 25636816 DOI: 10.1053/j.ajkd.2014.12.012] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 3.9] [Reference Citation Analysis]
23 Au EH, Wong G, Howard K, Chapman JR, Castells A, Roger SD, Bourke MJ, Macaskill P, Turner R, Lim WH, Lok CE, Diekmann F, Cross N, Sen S, Allen RD, Chadban SJ, Pollock CA, Tong A, Teixeira-Pinto A, Yang JY, Kieu A, James L, Craig JC. Factors Associated With Advanced Colorectal Neoplasia in Patients With CKD. Am J Kidney Dis 2021:S0272-6386(21)00823-4. [PMID: 34461168 DOI: 10.1053/j.ajkd.2021.07.011] [Reference Citation Analysis]
24 Ishimitsu A, Satonaka H, Furuichi M, Murayama Y, Tojo A, Ishimitsu T. Role of circulating endothelial progenitors in responsiveness to erythropoiesis-stimulating agents in hemodialysis patients. Ren Replace Ther 2021;7. [DOI: 10.1186/s41100-021-00374-4] [Reference Citation Analysis]
25 Cai KD, Zhu BX, Lin HX, Luo Q. Successful application of roxadustat in the treatment of patients with anti-erythropoietin antibody-mediated renal anaemia: a case report and literature review. J Int Med Res 2021;49:3000605211005984. [PMID: 33853432 DOI: 10.1177/03000605211005984] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Davani-Davari D, Karimzadeh I, Khalili H. The potential effects of anabolic-androgenic steroids and growth hormone as commonly used sport supplements on the kidney: a systematic review. BMC Nephrol 2019;20:198. [PMID: 31151420 DOI: 10.1186/s12882-019-1384-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
27 Thadhani R, Guilatco R, Hymes J, Maddux FW, Ahuja A. Switching from Epoetin Alfa (Epogen®) to Epoetin Alfa-Epbx (RetacritTM) Using a Specified Dosing Algorithm: A Randomized, Non-Inferiority Study in Adults on Hemodialysis. Am J Nephrol 2018;48:214-24. [PMID: 30196301 DOI: 10.1159/000492621] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]